Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Contacts and Locations
Related Studies
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)
Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1
Conditions listed in this trial
Colorectal Cancer
Esophageal Cancer
Gastric Cancer
Pancreatic Cancer
2
Additional conditions recognized in this trial
Adenocarcinoma
Colorectal Neoplasms
Esophageal Diseases
Esophageal Neoplasms
Pancreatic Neoplasms
Rectal Neoplasms
Stomach Neoplasms
3
More general conditions related to this trial
Carcinoma
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Head and Neck Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Pancreatic Diseases
Rectal Diseases
Stomach Diseases
4
Interventions listed in this trial
LMB-9 immunotoxin
5
Additional drug interventions recognized in this trial
Immunotoxins
6
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
7
Sponsors listed in this trial
University Hospital Freiburg
National Cancer Institute (NCI)
U.S. National Library of Medicine
,
Contact Help Desk
U.S. National Institutes of Health
,
U.S. Department of Health & Human Services
,
USA.gov
,
Copyright
,
Privacy
,
Accessibility
,
Freedom of Information Act
Links to all studies - primarily for crawlers